Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
The Scientific World Journal
Volume 2014, Article ID 393628, 7 pages
http://dx.doi.org/10.1155/2014/393628
Research Article

The Prevalence of Nonalcoholic Fatty Liver Disease and Relationship with Serum Uric Acid Level in Uyghur Population

1School of Nursing, Xinjiang Medical University, No. 168 Youhao South Road, Urumqi, Xinjiang 830000, China
2Department of Infectious Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, China
3School of Basic Medical Sciences of Xinjiang Medical University, No. 137 Liyushan South Road, Urumqi, Xinjiang 830054, China
4Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, No. 137 Liyushan South Road, Urumqi, Xinjiang 830054, China

Received 28 August 2013; Accepted 8 October 2013; Published 2 January 2014

Academic Editors: P. Toran and L. Yen

Copyright © 2014 Wen Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. U. Lan and D. Hong, “The research on the relationship between Nonalcoholic fatty liver disease and metabolic syndrome,” Foreign Medical Sciences, vol. 36, no. 6, pp. 383–385, 2009 (Chinese). View at Google Scholar
  2. S. Ryu, Y. Chang, S.-G. Kim, J. Cho, and E. Guallar, “Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men,” Metabolism, vol. 60, no. 6, pp. 860–866, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Hediger, R. J. Johnson, H. Miyazaki, and H. Endou, “Molecular physiology of urate transport,” Physiology, vol. 20, no. 2, pp. 125–133, 2005. View at Google Scholar · View at Scopus
  4. X. Dai, J. Yuan, and P. Yao, “Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population,” European Journal of Epidemiology, vol. 28, no. 8, pp. 669–676, 2013. View at Google Scholar
  5. Z. Soltani, K. Rasheed, D. R. Kapusta, and E. Reisin, “Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?” Current Hypertension Reports, vol. 15, no. 3, pp. 175–181, 2013. View at Google Scholar
  6. F. Ghaemi-Oskouie and Y. Shi, “The role of uric acid as an endogenous danger signal in immunity and inflammation,” Current Rheumatology Reports, vol. 13, no. 2, pp. 160–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Xiu-li and W. Meng, “The recent advances in the pathogenesis of nonalcoholic fatty liver disease,” Lishzhen Medicine and Materia Medica Research, vol. 21, no. 10, pp. 2647–2648, 2010 (Chinese). View at Google Scholar
  8. C. Xu, C. Yu, L. Xu, M. Miao, and Y. Li, “High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study,” PLoS ONE, vol. 5, no. 7, Article ID e11578, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. I.-C. Hwang, S.-Y. Suh, A.-R. Suh, and H.-Y. Ahn, “The relationship between normal serum uric acid and nonalcoholic fatty liver disease,” Journal of Korean Medical Science, vol. 26, no. 3, pp. 386–391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. W. Lee, Y. K. Cho, M. C. Ryan et al., “Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study,” Gut and Liver, vol. 4, no. 3, pp. 378–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-F. Kuo, K.-H. Yu, S.-F. Luo et al., “Gout and risk of non-alcoholic fatty liver disease,” Scandinavian Journal of Rheumatology, vol. 39, no. 6, pp. 466–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Petta, C. Cammà, D. Cabibi, V. Di Marco, and A. Craxì, “Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 7, pp. 757–766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. B. Vos, R. Colvin, P. Belt et al., “Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD,” Journal of Pediatric Gastroenterology and Nutrition, vol. 54, no. 1, pp. 90–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Kelishadi, R. S. Cook, A. Adibi et al., “Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults,” Journal of Pediatrics, vol. 89, no. 4, pp. 412–418, 2013. View at Google Scholar
  15. J. C. Sirota, K. McFann, G. Targher, R. J. Johnson, M. Chonchol, and D. I. Jalal, “Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey,” Metabolism, vol. 62, no. 3, pp. 392–399, 2013. View at Google Scholar
  16. A. S. Cardoso, N. C. Gonzaga, C. C. Medeiros, and D. F. Carvalho, “Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents,” Journal of Pediatrics, vol. 89, no. 4, pp. 412–418, 2013. View at Google Scholar
  17. Y. Li, C. Xu, C. Yu, L. Xu, and M. Miao, “Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study,” Journal of Hepatology, vol. 50, no. 5, pp. 1029–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Xie, M. Wang, Y. Zhang et al., “Serum uric acid and non-alcoholic fatty liver disease in non-diabetic chinese men,” PLoS One, vol. 8, no. 7, Article ID 67152, 2013. View at Google Scholar
  19. N. Li, H. Wang, Z. Yan, X. Yao, J. Hong, and L. Zhou, “Ethnic disparties in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study,” BMC Public Health, vol. 3, no. 12, pp. 499–511, 2012. View at Google Scholar
  20. X. Ying, Z. Rongjiong, and Z. Jun, “Epidemiological survey of prevalence of fatty liver and risk factors in the uyghur and han nationality patients of shuimogou district,” Xinjiang Medical Journal, vol. 41, no. 11, pp. 13–16, 2011 (Chinese). View at Google Scholar
  21. H. Yu-ying, Y. M. Aiti, and A. Aisha, “Epidemiological survey of hyperuricemia and gout in Uygur population of Xinjiang,” Journal of Chinese Practical Diagnosis and Therapy, vol. 27, no. 7, pp. 570–572, 2011. View at Google Scholar
  22. Workshop on fatty liver and Alcoholic Liver Disease for the Chinese Liver Disease Association, “Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition,” Chinese Journal of Gastroenterology Hepatology, vol. 19, no. 6, pp. 483–487, 2010 (Chinese). View at Google Scholar
  23. D. I. Feig, D.-H. Kang, and R. J. Johnson, “Uric acid and cardiovascular risk,” The New England Journal of Medicine, vol. 359, no. 17, pp. 1811–1821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-G. Fan, T. Saibara, S. Chitturi, B. I. Kim, J. J. Y. Sung, and A. Chutaputti, “What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?” Journal of Gastroenterology and Hepatology, vol. 22, no. 6, pp. 794–800, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-G. Fan and G. C. Farrell, “Epidemiology of non-alcoholic fatty liver disease in China,” Journal of Hepatology, vol. 50, no. 1, pp. 204–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Ken, Z. Ting, W. Qin-qin et al., “Study on the relevant study between non-alcoholic fatty liver disease and metabolic syndrome in Chengdu,” Modern Preventive Medicine, vol. 39, no. 10, pp. 2395–2397, 2012. View at Google Scholar
  27. Z. Ze-gao, X. Li, Z. Yue-xin et al., “Analysis of the prevalence of nonalcoholic fatty liver disease in uygur civil servants in urumqi,” Modern Preventive Medicine, vol. 39, no. 8, 1955 (Chinese). View at Google Scholar
  28. C. Chang-chun, W. Li, and M. Xiao-mei, “The survey overweight and obesity of Uyghur population above 35 years in Kashi,” Chinese Journal of Epidemiology, vol. 26, no. 2, article 119, 2005. View at Google Scholar
  29. L. Shu-fen and Z. Xue-jun, “Association between hyperuricemia and fatty liver,” Chinese Journal of Ailerg & Cunical Immunology, vol. 5, no. 2, pp. 109–112, 2011. View at Google Scholar
  30. S. H. Park, B. I. Kim, J. W. Yun et al., “Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men,” Journal of Gastroenterology and Hepatology, vol. 19, no. 6, pp. 694–698, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Dawson and M. Walters, “Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?” British Journal of Clinical Pharmacology, vol. 62, no. 6, pp. 633–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. I. García-Ruiz, C. Rodríguez-Juan, T. Díaz-Sanjuan et al., “Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice,” Hepatology, vol. 44, no. 3, pp. 581–591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. R. Hayden and S. C. Tyagi, “Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle,” Nutrition and Metabolism, vol. 1, no. 1, pp. 1–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. Patterson, E. T. M. Horsley, and D. S. Leake, “Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid,” Journal of Lipid Research, vol. 44, no. 3, pp. 512–521, 2003. View at Publisher · View at Google Scholar · View at Scopus